Multizentrische Therapieoptimierungsstudie zum Einsatz von Docetaxel (Taxotere) und Mitoxantron (Novantron) in der Therapie des hormonrefraktären Prostatakarzinoms
Loading...
Files
Date
Authors
Publisher
Philipps-Universität Marburg
Abstract
Our studie is a multicenter phase II trial with Docetaxel and mitoxantron in the therapie of hormone refractory prostate carcinom.
Review
Metadata
License
This item has been published with the following license: In Copyright